Skip to main content
VCYTHealthcare

Veracyte Inc (VCYT) Insider Trading

In the last 90 days, 6 Veracyte Inc (VCYT) insiders reported no open-market purchases and 7 sales totaling $1,388,916. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Oct 19, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Oct 19, 2026Muna BhanjiCorporate insiderSale1,864$43.70$81,457
Sep 21, 2026John LeiteGlobal Chief Commercial OffSale4,015$40.00$160,600
Sep 14, 2026Jens HolsteinCorporate insiderSale5,000$40.95$204,747
Sep 4, 2026Annie McGuireEVP, General CounselSale3,254$43.09$140,212
Sep 4, 2026Rebecca ChambersChief Financial OfficerSale3,652$43.10$157,394
Sep 4, 2026Phillip G. FebboChief Scientific & Med OfficerSale13,110$43.05$564,410
Sep 1, 2026Muna BhanjiCorporate insiderSale1,864$42.97$80,096
Jun 18, 2026Karin EasthamCorporate insiderSale3,729$52.89$197,234
Jun 4, 2026John LeiteGlobal Chief Commercial OffSale13,975$50.07$699,732
Jun 4, 2026Annie McGuireEVP, General CounselSale3,176$49.76$158,036

Common questions

VCYT insider trading FAQ

Are VCYT insiders buying or selling?
Over the last 90 days, VCYT insiders were net sellers, reporting $0.00 of open-market purchases and $1,388,916 of sales.
When was the last VCYT insider purchase?
No open-market insider purchase of Veracyte Inc stock was reported in the last 90 days.
Where does VCYT insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Veracyte Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.